搜索临床试验以:alb-干扰素α2b
总计3893个结果
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)终止
-
David W. RobertsNational Institute of Neurological Disorders and Stroke (NINDS); Carl Zeiss Meditec, Inc.招聘中
-
National Taiwan University HospitalNational Science Council, Taiwan完全的
-
Dermatologic Cooperative Oncology Group未知治疗 | 佐剂 | III期恶性黑色素瘤 | Interferon Alpha德国
-
M.D. Anderson Cancer CenterEisai Inc.终止
-
PharmaEssentia Japan K.K.PharmaEssentia完全的
-
National Institute of Allergy and Infectious Diseases...完全的
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)完全的未明确的儿童实体瘤,具体方案 | 恶性潜能未定的肿瘤美国
-
Hoffmann-La Roche完全的肾细胞癌 | 慢性粒细胞白血病 | 恶性黑色素瘤加拿大, 印度, 保加利亚, 俄罗斯联邦, 西班牙, 南非, 斯洛伐克
-
Mitsubishi Tanabe Pharma CorporationVertex Pharmaceuticals Incorporated完全的
-
Novartis PharmaceuticalsHuman Genome Sciences Inc.终止
-
Biofrontera Bioscience GmbH招聘中
-
Xiamen Amoytop Biotech Co., Ltd.Peking University People's Hospital完全的
-
Xiamen Amoytop Biotech Co., Ltd.Peking University First Hospital完全的
-
José Antonio CarrionInstituto de Salud Carlos III完全的慢性乙型肝炎(HBeAg 阴性)
-
Children's Oncology GroupNational Cancer Institute (NCI); University College, London; Medical Research Council完全的
-
Chinese University of Hong KongHoffmann-La Roche完全的
-
Indivior Inc.AESCA Pharma GmbH终止
-
Innovent Biologics (Suzhou) Co. Ltd.终止
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Schering-Plough完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Horizon Pharma USA, Inc.终止
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)终止
-
Masonic Cancer Center, University of Minnesota终止
-
University of Miami完全的
-
Vir Biotechnology, Inc.Alnylam Pharmaceuticals主动,不招人
-
Institute of Cancer Research, United Kingdom完全的
-
Hackensack Meridian HealthNational Cancer Institute (NCI)撤销